These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35151192)

  • 1. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study.
    Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C
    Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
    Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
    Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.
    Rodríguez-Uranga JJ; Sánchez-Caro JM; Hariramani Ramchandani R
    Epilepsia Open; 2024 Aug; 9(4):1345-1356. PubMed ID: 38800945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience combined with therapeutic drug monitoring of lacosamide.
    Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
    Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
    Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
    Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
    [No Abstract]   [Full Text] [Related]  

  • 6. Lacosamide in patients with intellectual disability and refractory epilepsy.
    Kleist A; Kerling F; Hamer H; Winterholler M
    Acta Neurol Belg; 2019 Sep; 119(3):423-430. PubMed ID: 30840220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
    Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
    CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
    Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
    Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of add-on therapy with newer-generation antiepileptic drugs in Bulgarian patients with refractory epilepsy.
    Viteva E; Zahariev Z
    Epilepsy Behav; 2018 Oct; 87():137-145. PubMed ID: 30097339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide add-on therapy for partial epilepsy.
    Weston J; Shukralla A; McKay AJ; Marson AG
    Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.
    Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J
    CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
    Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
    Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study.
    Zhao T; Yu LH; Zhang HL; Yu J; Feng J; Wang TT; Sun Y; Li HJ
    BMC Pediatr; 2023 May; 23(1):249. PubMed ID: 37210552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.